1,573
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis

, , &
Pages 878-885 | Received 30 Jun 2022, Accepted 25 Apr 2023, Published online: 05 Jun 2023

References

  • Abid MR, Yano K, Guo S, Patel VI, Shrikhande G, Spokes KC, Ferran C, Aird WC. 2005. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J Biol Chem. 280(33):29864–29873.
  • Armanini D, Boscaro M, Bordin L, Sabbadin C. 2022. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. IJMS. 23(8):4110.
  • Azziz R. 2018. Polycystic ovary syndrome. Obstet Gynecol. 132(2):321–336.
  • Begum Y. 2022. Regulatory role of microRNAs (miRNAs) in the recent development of abiotic stress tolerance of plants. Gene. 821:146283.
  • Beretta GL, Corno C, Zaffaroni N, Perego P. 2019. Role of FoxO proteins in cellular response to antitumor agents. Cancers (Basel). 11(1):90.
  • Chen B, Xu P, Wang J, Zhang C. 2019. The role of miRNA in polycystic ovary syndrome (PCOS). Gene. 706:91–96.
  • Chen J, Li Z, Chen AY, Ye X, Luo H, Rankin GO, Chen YC. 2013. Inhibitory effect of baicalin and baicalein on ovarian cancer cells. Int J Mol Sci. 14(3):6012–6025.
  • Deb B, Uddin A, Chakraborty S. 2018. miRNAs and ovarian cancer: an overview. J Cell Physiol. 233(5):3846–3854.
  • Fan H, He J, Bai Y, He Q, Zhang T, Zhang J, Yang G, Xu Z, Hu J, Yao G. 2022. Baicalin improves the functions of granulosa cells and the ovary in aged mice through the mTOR signaling pathway. J Ovarian Res. 15(1):34.
  • Ji R, Jia FY, Chen X, Wang ZH, Jin WY, Yang J. 2022. Salidroside alleviates oxidative stress and apoptosis via AMPK/Nrf2 pathway in DHT-induced human granulosa cell line KGN. Arch Biochem Biophys. 715:109094.
  • Jin P, Xie Y. 2018. Treatment strategies for women with polycystic ovary syndrome. Gynecol Endocrinol. 34(4):272–277.
  • Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, Boyle J, Teede HJ. 2022. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 10(9):668–680.
  • Khmil M, Khmil Doswald A, Halnykina S, Khmil S. 2022. Hormonal profile in women with infertility against the background of polycystic ovary syndrome depending on the type of pre-pregnancy pre-treatment. Pol Merkur Lekarski. 50(300):333–336.
  • Kuscu N, Celik-Ozenci C. 2015. FOXO1, FOXO3, AND FOXO4 are differently expressed during mouse oocyte maturation and preimplantation embryo development. Gene Expr Patterns. 18(1-2):16–20.
  • Li Y, Yao N, Gao Y, Wang Y, Bai L, Xu J, Wang H. 2021. MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O 1. Bioengineered. 12(1):8555–8569.
  • Liao H, Ye J, Gao L, Liu Y. 2021. The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: a comprehensive review. Biomed Pharmacother. 133:110917.
  • Lin X, Yang F, Qi X, Li Q, Wang D, Yi T, Yin R, Zhao X, Zhong X, Bian C. 2019. LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145. Mol Carcinog. 58(12):2286–2296.
  • Liu J, Zhao Y, Chen L, Li R, Ning Y, Zhu X. 2022. Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR‑223/GLUT4 and SNHG20/miR‑4486/GLUT4 signaling. Mol Med Rep. 26(1):218.
  • Martins R, Lithgow GJ, Link W. 2016. Long live FOXO: unraveling the role of FOXO proteins in aging and longevity. Aging Cell. 15(2):196–207.
  • McAllister JM, Han AX, Modi BP, Teves ME, Mavodza GR, Anderson ZL, Shen T, Christenson LK, Archer KJ, Strauss JF. 2019. miRNA profiling reveals miRNA-130b-3p mediates DENND1A variant 2 expression and androgen biosynthesis. Endocrinology. 160(8):1964–1981.
  • Mendoza N, Losa F, Palacios S. 2022. Strategy to improve the female fertility in the general gynecologist’s office: use of a nutritional supplement based on myo-inositol/d-chiro-inositol and antioxidants. Gynecol Endocrinol. 38(4):275–278.
  • Morris BJ, Willcox DC, Donlon TA, Willcox BJ. 2015. FOXO3: a major gene for human longevity–a mini-review. Gerontology. 61(6):515–525.
  • Murtaza G, Khan AK, Rashid R, Muneer S, Hasan SMF, Chen J. 2017. FOXO transcriptional factors and long-term living. Oxid Med Cell Longev. 2017:3494289.
  • Naderpoor N, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ. 2015. Obesity and polycystic ovary syndrome. Minerva Endocrinol. 40(1):37–51.
  • Patel S. 2018. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 182:27–36.
  • Pervaz S, Ullah A, Adu-Gyamfi EA, Lamptey J, Sah SK, Wang MJ, Wang YX. 2023. Role of CPXM1 in impaired glucose metabolism and ovarian dysfunction in polycystic ovary syndrome. Reprod Sci. 30(2):526–543.
  • Qiu Z, Dong J, Xue C, Li X, Liu K, Liu B, Cheng J, Huang F. 2020. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway. J Ethnopharmacol. 250:111965.
  • Shafienia H, Montazeri F, Heydari L, Khalili MA, Mazloomzadeh S, Sheikhha MH, Biglari A. 2022. Target gene repression mediated by miR-144 and miR-224 in cumulus cells is related to the success of oocyte in vitro maturation and fertilization in patients with polycystic ovary syndrome (PCOS). Reprod Fertil Dev. 34(17):1089–1098.
  • Tsuzuki M, Watanabe Y. 2017. Profiling new small RNA sequences. Methods Mol Biol. 1456:177–188.
  • Wang S, Wang C, Liu O, Hu Y, Li X, Lin B. 2022. miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway. Biochem Biophys Res Commun. 619:76–83.
  • Wang W, Zheng J, Cui N, Jiang L, Zhou H, Zhang D, Hao G. 2019. Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase. J Ovarian Res. 12(1):109.
  • Wei Q, Hao X, Lau BW, Wang S, Li Y. 2022. Baicalin regulates stem cells as a creative point in the treatment of climacteric syndrome. Front Pharmacol. 13:986436.
  • Wei Y, Wang Z, Wei L, Li S, Qiu X, Liu C. 2021. MicroRNA-874-3p promotes testosterone-induced granulosa cell apoptosis by suppressing HDAC1-mediated p53 deacetylation. Exp Ther Med. 21(4):359.
  • Xia B, Lin M, Dong W, Chen H, Li B, Zhang X, Hou Y, Lou G. 2018. Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2. J Biochem Mol Toxicol. 32(8):e22168.
  • Xu Y, Tang J, Guo Q, Xu Y, Yan K, Wu L, Xie K, Zhu A, Rong X, Ye D, et al. 2021. Traditional Chinese medicine formula FTZ protects against polycystic ovary syndrome through modulating adiponectin-mediated fat-ovary crosstalk in mice. J Ethnopharmacol. 268:113587.
  • Yi W, Li X, Chen K, Li J, Chen K, Pan A. 2020. Effect of rNA interference on Oatp3a1 gene expression on biological characteristics and immune factors of ovarian granulosa cells in rats with PCOS. Am J Transl Res. 12:4659–4668.
  • Yu J, Liu Y, Zhang D, Zhai D, Song L, Cai Z, Yu C. 2019. Baicalin inhibits recruitment of GATA1 to the HSD3B2 promoter and reverses hyperandrogenism of PCOS. J Endocrinol. 240(3):497–507.
  • Yu Y, Li G, He X, Lin Y, Chen Z, Lin X, Xu H. 2021. MicroRNA-21 regulate the cell apoptosis and cell proliferation of polycystic ovary syndrome (PCOS) granulosa cells through target toll like receptor TLR8. Bioengineered. 12(1):5789–5796.
  • Zhang J, Bao Y, Zhou X, Zheng L. 2019. Polycystic ovary syndrome and mitochondrial dysfunction. Reprod Biol Endocrinol. 17(1):67.
  • Zhang J, Xu Y, Liu H, Pan Z. 2019. MicroRNAs in ovarian follicular atresia and granulosa cell apoptosis. Reprod Biol Endocrinol. 17(1):9.
  • Zhao H, Zhou D, Chen Y, Liu D, Chu S, Zhang S. 2017. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway. Daru. 25(1):21.
  • Zong ZH, Du YP, Guan X, Chen S, Zhao Y. 2019. CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182. J Exp Clin Cancer Res. 38(1):437.